首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1591300篇
  免费   131939篇
  国内免费   2522篇
耳鼻咽喉   21608篇
儿科学   52814篇
妇产科学   46119篇
基础医学   225944篇
口腔科学   47142篇
临床医学   139549篇
内科学   311709篇
皮肤病学   34151篇
神经病学   129217篇
特种医学   64704篇
外国民族医学   474篇
外科学   243293篇
综合类   39663篇
一般理论   548篇
预防医学   121941篇
眼科学   36316篇
药学   120938篇
  2篇
中国医学   2880篇
肿瘤学   86749篇
  2018年   14565篇
  2016年   12778篇
  2015年   14903篇
  2014年   20613篇
  2013年   31345篇
  2012年   42620篇
  2011年   44803篇
  2010年   26332篇
  2009年   25313篇
  2008年   43066篇
  2007年   45307篇
  2006年   46081篇
  2005年   44741篇
  2004年   44166篇
  2003年   42197篇
  2002年   41305篇
  2001年   75658篇
  2000年   78225篇
  1999年   66046篇
  1998年   16736篇
  1997年   15359篇
  1996年   15304篇
  1995年   15964篇
  1994年   15008篇
  1993年   14165篇
  1992年   55416篇
  1991年   53813篇
  1990年   52577篇
  1989年   50843篇
  1988年   47225篇
  1987年   46560篇
  1986年   44300篇
  1985年   42856篇
  1984年   32011篇
  1983年   27540篇
  1982年   16106篇
  1981年   14391篇
  1980年   13506篇
  1979年   30448篇
  1978年   21043篇
  1977年   17703篇
  1976年   16631篇
  1975年   17506篇
  1974年   21432篇
  1973年   20631篇
  1972年   18830篇
  1971年   17744篇
  1970年   16270篇
  1969年   15244篇
  1968年   13936篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Modified-release opioids are often prescribed for the management of moderate to severe acute pain following total hip and knee arthroplasty, despite recommendations against their use due to increasing concerns regarding harm. The primary objective of this multicentre study was to examine the impact of modified-release opioid use on the incidence of opioid-related adverse events compared with immediate-release opioid use, among adult inpatients following total hip or knee arthroplasty. Data for total hip and knee arthroplasty inpatients receiving an opioid analgesic for postoperative analgesia during hospitalisation were collected from electronic medical records of three tertiary metropolitan hospitals in Australia. The primary outcome was the incidence of opioid-related adverse events during hospital admission. Patients who received modified with or without immediate-release opioids were matched to those receiving immediate-release opioids only (1:1) using nearest neighbour propensity score matching with patient and clinical characteristics as covariates. This included total opioid dose received. In the matched cohorts, patients given modified-release opioids (n = 347) experienced a higher incidence of opioid-related adverse events overall, compared with those given immediate-release opioids only (20.5%, 71/347 vs. 12.7%, 44/347; difference in proportions 7.8% [95%CI 2.3–13.3%]). Modified-release opioid use was associated with an increased risk of harm when used for acute pain during hospitalisation after total hip or knee arthroplasty.  相似文献   
3.
Pharmaceutical Chemistry Journal - Metformin hydrochloride is widely used to treat diabetes mellitus. This review presents its physical and chemical properties and discusses methods of analysis...  相似文献   
4.
Khadka  J.  Ratcliffe  J.  Hutchinson  C.  Cleland  J.  Mulhern  B.  Lancsar  E.  Milte  R. 《Quality of life research》2022,31(9):2849-2865
Quality of Life Research - To evaluate the construct (convergent and known group) validity of the Quality-of-Life-Aged Care Consumer (QOL-ACC), an older-person-specific quality-of-life measure...  相似文献   
5.
6.
7.
8.
9.
PurposeTRAPPC9 deficiency is an autosomal recessive disorder mainly associated with intellectual disability (ID), microcephaly, and obesity. Previously, TRAPPC9 deficiency has not been associated with biochemical abnormalities.MethodsExome sequencing was performed in 3 individuals with ID and dysmorphic features. N-Glycosylation analyses were performed in the patients’ blood samples to test for possible congenital disorder of glycosylation (CDG). TRAPPC9 gene, TRAPPC9 protein expression, and N-glycosylation markers were assessed in patient fibroblasts. Complementation with wild-type TRAPPC9 and immunofluorescence studies to assess TRAPPC9 expression and localization were performed. The metabolic consequences of TRAPPC9 deficiency were evaluated using tracer metabolomics.ResultsAll 3 patients carried biallelic missense variants in TRAPPC9 and presented with an N-glycosylation defect in blood, consistent with CDG type I. Extensive investigations in patient fibroblasts corroborated TRAPPC9 deficiency and an N-glycosylation defect. Tracer metabolomics revealed global metabolic changes with several affected glycosylation-related metabolites.ConclusionWe identified 3 TRAPPC9 deficient patients presenting with ID, dysmorphic features, and abnormal glycosylation. On the basis of our findings, we propose that TRAPPC9 deficiency could lead to a CDG (TRAPPC9-CDG). The finding of abnormal glycosylation in these patients is highly relevant for diagnosis, further elucidation of the pathophysiology, and management of the disease.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号